Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis

PLoS One. 2021 Aug 5;16(8):e0255574. doi: 10.1371/journal.pone.0255574. eCollection 2021.

Abstract

Objectives: In alcoholic hepatitis (AH), dysfunctional T lymphocytes may contribute to the high mortality from infections. T lymphocyte activation is governed by the expression of co-stimulatory receptors such as 4-1BB balanced by inhibitory receptors such as Programmed Death receptor 1 (PD-1). 4-1BB expression is unaccounted for in AH, while PD-1 is elevated. We characterized expression of 4-1BB and PD-1 and the associated T lymphocyte functional status in AH and investigated whether these were associated with short-term mortality.

Methods: Thirty-five patients with AH (at diagnosis and days 7 and 90) were compared with healthy controls (HC). Spontaneous and in vitro stimulated receptor expression were quantified by flow cytometry, and plasma proteins by ELISA.

Results: At diagnosis, the patients showed increased stimulated 4-1BB responses of CD4+ T lymphocytes. Also, the frequencies of PD-1+ T lymphocytes both with and without co-expressed 4-1BB were increased. Further, interferon-gamma was predominantly produced in T lymphocytes co-expressing 4-1BB. A decrease in the frequency of spontaneous 4-1BB+ T lymphocytes and an increase in soluble 4-1BB during the first week after diagnosis were associated with higher mortality at day 90 in AH. PD-1 expression showed no systematic dynamics related to mortality.

Conclusions: We found an increased stimulated 4-1BB response of T lymphocytes in AH and early loss of these lymphocytes was associated with a higher short-term mortality. This suggests a role of T lymphocyte 4-1BB expression in the progression of AH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B7-H1 Antigen / metabolism*
  • CD4-Positive T-Lymphocytes / immunology*
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Galectins / metabolism*
  • Hepatitis, Alcoholic / epidemiology
  • Hepatitis, Alcoholic / immunology
  • Hepatitis, Alcoholic / metabolism
  • Hepatitis, Alcoholic / mortality*
  • Humans
  • Lymphocyte Activation / immunology*
  • Male
  • Middle Aged
  • Prognosis
  • Survival Rate
  • Time Factors
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / metabolism*

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Galectins
  • TNFRSF9 protein, human
  • Tumor Necrosis Factor Receptor Superfamily, Member 9

Grants and funding

LLE received 150.000 DKK from Novo Nordisk Foundation (https://novonordiskfonden.dk/en/) and 100.000 DKK from Aase og Ejnar Danielsens Fond (https://danielsensfond.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.